Literature DB >> 20665848

Quantitative evaluation of mefenamic acid polymorphs by terahertz-chemometrics.

Makoto Otsuka1, Jun-ichi Nishizawa, Jiro Shibata, Masahiko Ito.   

Abstract

The purpose of the present study is to measure polymorphic content in a bulk powder, mefenamic acid polymorph of pharmaceuticals, as a model drug by THz-spectrometer using frequency-tunable THz wave generators based on difference-frequency generation in gallium phosphate crystals. Mefenamic acid polymorphic forms I and II were obtained by recrystallisation. Eleven standard samples varying a various polymorphic form I content (0-100%) were prepared by physical mixing. After smoothing and area normalising, the THz-spectra of all standard samples showed an isosbestic point at 3.70 THz. After the THz-spectral data sets were arranged into five frequency ranges, and pretreated using various functions, calibration models were calculated by the partial least square regression method. The effect of spectral data management on the chemometric parameters of the calibration models was investigated. The relationship between predicted and actual form I content was the best linear plot. On the regression vector (RV) that corresponded to absorption THz-spectral data, the peak at 1.45 THz was the highest value, and the peak at 2.25 THz was the lowest on RV. THz-spectroscopy with chemometrics would be useful for the quantitative evaluation of mefenamic acid polymorphs in the pharmaceutical industry. This method is expected to provide a rapid and nondestructive quantitative analysis of polymorphs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20665848     DOI: 10.1002/jps.22194

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  Applying terahertz technology for nondestructive detection of crack initiation in a film-coated layer on a swelling tablet.

Authors:  Wataru Momose; Hiroyuki Yoshino; Yoshifumi Katakawa; Kazunari Yamashita; Keiji Imai; Kazuhiro Sako; Eiji Kato; Akiyoshi Irisawa; Etsuo Yonemochi; Katsuhide Terada
Journal:  Results Pharma Sci       Date:  2012-04-13

2.  Far-Infrared Spectroscopy as a Probe for Polymorph Discrimination.

Authors:  Kuthuru Suresh; Jeffrey S Ashe; Adam J Matzger
Journal:  J Pharm Sci       Date:  2018-12-30       Impact factor: 3.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.